Cargando…

Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system

BACKGROUND: Increasing evidence supports a key role for inflammation in the neurodegenerative process of familial amyloidotic polyneuropathy (FAP). While there seems to be an overactivation of the neuronal interleukin-1 signaling pathway, the immune response is apparently compromised in FAP. Accordi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Nádia Pereira, Moreira, João, Martins, Diana, Vieira, Paulo, Obici, Laura, Merlini, Giampaolo, Saraiva, Margarida, Saraiva, Maria João
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460450/
https://www.ncbi.nlm.nih.gov/pubmed/28583160
http://dx.doi.org/10.1186/s12974-017-0891-9
_version_ 1783242176396787712
author Gonçalves, Nádia Pereira
Moreira, João
Martins, Diana
Vieira, Paulo
Obici, Laura
Merlini, Giampaolo
Saraiva, Margarida
Saraiva, Maria João
author_facet Gonçalves, Nádia Pereira
Moreira, João
Martins, Diana
Vieira, Paulo
Obici, Laura
Merlini, Giampaolo
Saraiva, Margarida
Saraiva, Maria João
author_sort Gonçalves, Nádia Pereira
collection PubMed
description BACKGROUND: Increasing evidence supports a key role for inflammation in the neurodegenerative process of familial amyloidotic polyneuropathy (FAP). While there seems to be an overactivation of the neuronal interleukin-1 signaling pathway, the immune response is apparently compromised in FAP. Accordingly, little immune cell infiltration is observed around pre-fibrillar or fibrillar amyloid deposits, with the underlying mechanism for this phenomenon remaining poorly understood. Cathepsin E (CtsE) is an important intermediate for antigen presentation and chemotaxis, but its role in the pathogenesis of FAP disease remains unknown. METHODS: In this study, we used both mouse primary macrophages and in vivo studies based on transgenic models of FAP and human samples to characterize CtsE expression in different physiological systems. RESULTS: We show that CtsE is critically decreased in bone marrow-derived macrophages from a FAP mouse model, possibly contributing for cell function impairment. Compromised levels of CtsE were also found in injured nerves of transgenic mice and, most importantly, in naïve peripheral nerves, sensory ganglia, murine stomach, and sural nerve biopsies derived from FAP patients. Expression of CtsE in tissues was associated with transthyretin (TTR) deposition and differentially regulated accordingly with the physiological system under study. Preventing deposition with a TTR small interfering RNA rescued CtsE in the peripheral nervous system (PNS). In contrast, the expression of CtsE increased in splenic cells (mainly monocytes) or peritoneal macrophages, indicating a differential macrophage phenotype. CONCLUSION: Altogether, our data highlights the potential of CtsE as a novel FAP biomarker and a possible modulator for innate immune cell chemotaxis to the disease most affected tissues—the peripheral nerve and the gastrointestinal tract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0891-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5460450
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54604502017-06-07 Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system Gonçalves, Nádia Pereira Moreira, João Martins, Diana Vieira, Paulo Obici, Laura Merlini, Giampaolo Saraiva, Margarida Saraiva, Maria João J Neuroinflammation Research BACKGROUND: Increasing evidence supports a key role for inflammation in the neurodegenerative process of familial amyloidotic polyneuropathy (FAP). While there seems to be an overactivation of the neuronal interleukin-1 signaling pathway, the immune response is apparently compromised in FAP. Accordingly, little immune cell infiltration is observed around pre-fibrillar or fibrillar amyloid deposits, with the underlying mechanism for this phenomenon remaining poorly understood. Cathepsin E (CtsE) is an important intermediate for antigen presentation and chemotaxis, but its role in the pathogenesis of FAP disease remains unknown. METHODS: In this study, we used both mouse primary macrophages and in vivo studies based on transgenic models of FAP and human samples to characterize CtsE expression in different physiological systems. RESULTS: We show that CtsE is critically decreased in bone marrow-derived macrophages from a FAP mouse model, possibly contributing for cell function impairment. Compromised levels of CtsE were also found in injured nerves of transgenic mice and, most importantly, in naïve peripheral nerves, sensory ganglia, murine stomach, and sural nerve biopsies derived from FAP patients. Expression of CtsE in tissues was associated with transthyretin (TTR) deposition and differentially regulated accordingly with the physiological system under study. Preventing deposition with a TTR small interfering RNA rescued CtsE in the peripheral nervous system (PNS). In contrast, the expression of CtsE increased in splenic cells (mainly monocytes) or peritoneal macrophages, indicating a differential macrophage phenotype. CONCLUSION: Altogether, our data highlights the potential of CtsE as a novel FAP biomarker and a possible modulator for innate immune cell chemotaxis to the disease most affected tissues—the peripheral nerve and the gastrointestinal tract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0891-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-06 /pmc/articles/PMC5460450/ /pubmed/28583160 http://dx.doi.org/10.1186/s12974-017-0891-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gonçalves, Nádia Pereira
Moreira, João
Martins, Diana
Vieira, Paulo
Obici, Laura
Merlini, Giampaolo
Saraiva, Margarida
Saraiva, Maria João
Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title_full Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title_fullStr Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title_full_unstemmed Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title_short Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
title_sort differential expression of cathepsin e in transthyretin amyloidosis: from neuropathology to the immune system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460450/
https://www.ncbi.nlm.nih.gov/pubmed/28583160
http://dx.doi.org/10.1186/s12974-017-0891-9
work_keys_str_mv AT goncalvesnadiapereira differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT moreirajoao differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT martinsdiana differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT vieirapaulo differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT obicilaura differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT merlinigiampaolo differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT saraivamargarida differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem
AT saraivamariajoao differentialexpressionofcathepsineintransthyretinamyloidosisfromneuropathologytotheimmunesystem